ICD-9-CM 282.44 will be replaced by an equivalent ICD-10-CM code (or codes) when the United States transitions from ICD-9-CM to ICD-10-CM on October 1, 2015.
ICD-9-CM 282.44 is a billable medical code that can be used to specify a diagnosis on a reimbursement claim.
Beta plus thalassemia
Beta thalassemia major
Beta zero thalassemia
Homozygous beta thalassemia
Thalassemia, beta plus
Thalassemia, beta zero
Thalassemia, beta, homozygous
A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin a synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, cooley's anemia, mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin a synthesis is absent.
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 282.44 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2014 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.